A1C: Recommendations, debates, and questions

Diabetes Care

Volumn 32, Issue 12, 2009, Pages

  Bloomgarden, Zachary T ^a,b  

^a Mount Sinai School of Medicine ^*

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; HEMOGLOBIN C; HEMOGLOBIN D; HEMOGLOBIN F; HEMOGLOBIN S; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CARBAMOYLATION; CELL MEMBRANE PERMEABILITY; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIABETES MELLITUS; DIAGNOSTIC VALUE; ERYTHROCYTE LIFESPAN; ETHNICITY; FRUCTOSAMINE BLOOD LEVEL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCATION; GLYCOLYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; IRON DEFICIENCY ANEMIA; LIPOPROTEIN BLOOD LEVEL; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHOTOGRAPHY; PREGNANCY; RETINA DISEASE; UREMIA;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 72249090820     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-zb12     Document Type: Conference Paper

References (51)

1. Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971;284:353-357
2. Duncan BB, Heiss G. Nonenzymatic glycosylation of proteins - a new tool for assessment of cumulative hyperglycemia in epidemiologic studies, past and future. Am J Epidemiol 1984;120:169-189 (Pubitemid 14052610)
3. American Diabetes Association. Standards of medical care in diabetes - 2009 (Position Statement). Diabetes Care 2009;32(Suppl. 1):S13-S61
4. American College of Endocrinology. Consensus Statement on Guidelines for Glycemic Control. Endocr Pract 2002;8(Suppl. 1):5-11
5. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334
6. Vistisen D, Colagiuri S, Borch-Johnsen K, DETECT-2 Collaboration. Bimodal distribution of glucose is not universally useful for diagnosing diabetes. Diabetes Care 2009;32:397-403
7. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, Knowler WC. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994;308:1323-1328 (Pubitemid 2080582)
8. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197
9. World Heath Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1. Report of a WHOConsultation: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999
10. Weykamp C, John WG, Mosca A, Hoshino T, Little R, Jeppsson JO, Goodall I, Miedema K, Myers G, Reinauer H, Sacks DB, Slingerland R, Siebelder C. The IFCC Reference Measurement System for HbA1c: a 6-year progress report. Clin Chem 2008;54:240-248 (Pubitemid 351302616)
11. Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, Madsen R, Goldstein D. Biological variation of glycohemoglobin. Clin Chem 2002;48:1116-1118
12. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007;167:1545-1551 (Pubitemid 47124186)
13. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE, Australian Diabetes Obesity and Lifestyle Study Group. Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2008;31:1349-1354
14. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000;23:1108-1112
15. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E, DESIR Study Group. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006;29:1619-1625 (Pubitemid 44127590)
16. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 2004;19:1175-1180 (Pubitemid 40041381)
17. Bloomgarden ZT, Inzucchi SE, Karnieli E, Le Roith D. The proposed terminology 'A(1c)-derived average glucose' is inherently imprecise and should not be adopted. Diabetologia 2008;51:1111-1114
18. Gallagher E, Le Roith D, Bloomgarden Z. Review of hemoglobin A1c in the management of diabetes. J Diabetes 2009;1:9-17
19. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 2001;50:2858-2863 (Pubitemid 33733139)
20. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004;112:126-128 (Pubitemid 39274157)
21. Tarim O, Küçükerdoǧan A, Günay U, Eralp O, Ercan I. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int 1999;41:357-362 (Pubitemid 29376974)
22. Hashimoto K, Noguchi S, Morimoto Y, Hamada S, Wasada K, Imai S, Murata Y, Kasayama S, Koga M. A1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care 2008;31:1945-1948
23. Koga M, Morita S, Saito H, Mukai M, Kasayama S. Association of erythrocyte indices with glycated haemoglobin in premenopausal women. Diabet Med 2007;24:843-847 (Pubitemid 47093042)
24. Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care 2004;27:931-935
25. Herranz L, Saez-de-Ibarra L, Grande C, Pallardo LF. Non-glycemic- dependent reduction of late pregnancy A1C levels in women with type 1 diabetes. Diabetes Care 2007;30:1579-1580 (Pubitemid 46871175)
26. Sabanayagam C, Liew G, Tai ES, Shankar A, Lim SC, Subramaniam T, Wong TY. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 2009;52:1279-1289
27. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-2453 (Pubitemid 352008502)
28. Schweet R, Lamfrom H, Allen E. The synthesis of hemoglobin in a cell-free system. Proc Natl Acad Sci U S A 1958;44:1029-1035
29. Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 1969;36:838-843
30. Svendsen PA, Lauritzen T, Søegaard U, Nerup J. Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia 1982;23:403-405 (Pubitemid 12037379)
31. Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 1984;310:341-346 (Pubitemid 14179538)
32. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478
33. Iqbal N, Morgan C, Maksoud H, Idris I. Improving patients' knowledge on the relationship between HbA1c and mean plasma glucose improves glycemic control among persons with poorly controlled diabetes. Ann Clin Biochem 2008;45:504-507
34. Kim PS, Woods C, Georgoff P, Crum D, Rosenberg A, Smith M, Hadigan C. A1C underestimates glycemia in HIV infection. Diabetes Care 2009;32:1591-1593
35. Peacock TP, Shihabi ZK, Bleyer AJ, Dolbare EL, Byers JR, Knovich MA, Calles- Escandon J, Russell GB, Freedman BI. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 2008;73:1062-1068
36. Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, Sullivan L, D'Agostino RB, Nathan DM. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008;31:1991-1996
37. Kilpatrick ES, Dominiczak MH, Small M. The effects of ageing on glycation and the interpretation of glycaemic control in Type 2 diabetes. Q J Med 1996;89:307-312 (Pubitemid 26107747)
38. Selvin E, Zhu H, Brancati FL. Elevated A1C in adults without a history of diabetesinthe U. S. Diabetes Care 2009;32:828-833
39. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E, Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2453-2457
40. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002;16:313-320
41. Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003;26:163-167
42. McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 2004;27:1259-1264 (Pubitemid 38679967)
43. Diabetes Research in Children Network (DirecNet) Study Group, Wilson DM, Kollman. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care 2008;31:381-385
44. Kahn R, Fonseca V. Translating the A1C Assay. Diabetes Care 2008;31:1704-1707
45. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
46. Brown JN, Kemp DW, Brice KR. Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis. Pharmacotherapy 2009;29:468-472
47. Kilpatrick ES, Maylor PW, Keevil BG. Biological variation of glycated hemoglobin: implications for diabetes screening and monitoring. Diabetes Care 1998;21:261-264
48. Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, Palascak MB, Joiner CH. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284-4291
49. Khera PK, Joiner CH, Carruthers A, Lindsell CJ, Smith EP, Franco RS, Holmes YR, Cohen RM. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes 2008;57:2445-2452
50. Cohen RM. A1C: does one size fit all? Diabetes Care 2007;30:2756-2758
51. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009;373:2215-2221